Nalidixic Acid

CHEMBL5 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

232.2 g/mol

LogP

1.4

Phase

4

This early antibiotic of the quinolone class is used to treat urinary tract infections caused by susceptible bacteria. It works by interfering with the bacteria's ability to copy their DNA, preventing them from multiplying.

Berat Molekul

232,2300 g/mol

LogP

1,40

TPSA

70,50 Å²

Lipinski RO5

Lulus

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21

InChI

InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17)

Molecular Formula

C12H12N2O3

HBD / HBA

1 / 5

Ikatan yang Dapat Dirotasi

2

Atom Berat

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This early antibiotic of the quinolone class is used to treat urinary tract infections caused by susceptible bacteria. It works by interfering with the bacteria's ability to copy their DNA, preventing them from multiplying.

Yes, Nalidixic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL5. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4421. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Mencari informasi yang ramah bagi pasien?

Nalidixic Acid di PillFYI

Struktur

Data Cepat

Rumus: C12H12N2O3

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.